Cargando…

Epidemiology and Clinical Features of Thyroid-associated Orbitopathy in Accra

PURPOSE: Thyroid-associated orbitopathy (TAO), a clinical manifestation of Graves' disease, is an autoimmune disorder of the orbital and periorbital tissue. Data on the epidemiology and clinical presentation of TAO in Africa are generally scarce and unavailable in Ghana. We investigated the epi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ackuaku-Dogbe, Edith Mawunyo, Akpalu, Josephine, Abaidoo, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793449/
https://www.ncbi.nlm.nih.gov/pubmed/29422752
http://dx.doi.org/10.4103/meajo.MEAJO_91_17
_version_ 1783296955679506432
author Ackuaku-Dogbe, Edith Mawunyo
Akpalu, Josephine
Abaidoo, Benjamin
author_facet Ackuaku-Dogbe, Edith Mawunyo
Akpalu, Josephine
Abaidoo, Benjamin
author_sort Ackuaku-Dogbe, Edith Mawunyo
collection PubMed
description PURPOSE: Thyroid-associated orbitopathy (TAO), a clinical manifestation of Graves' disease, is an autoimmune disorder of the orbital and periorbital tissue. Data on the epidemiology and clinical presentation of TAO in Africa are generally scarce and unavailable in Ghana. We investigated the epidemiology and clinical features of TAO among patients with thyroid disorders attending the Korle Bu Teaching Hospital, Accra. SUBJECTS AND METHODS: This was a descriptive cross-sectional study of patients diagnosed with thyroid disorders which was conducted at the endocrine and orbital clinics of the Korle Bu Teaching Hospital. Diagnosis was based on clinical features and confirmed by a thyroid function test. Data collected and analyzed included demography, systemic and ocular features of thyroid disorder, and thyroid function tests. RESULTS: Of the 194 patients with thyroid disorders recruited, 117 (60.30%) had TAO. The mean age was 45.22 years (standard deviation: 13.90). The male:female ratio was 1:4.45. The most common ocular symptoms were “bulging eyes” (76/65.00%) and “puffy eyelid” (62/53.00%), and the common signs were eyelid retraction (97/82.91%) and proptosis (80/68.38%). Mild TAO was diagnosed in 64.96% of patients with only 6.84% having the severe form. The outcomes of the thyroid function test, thyroid disorder, and severity of TAO did not record any statistically significant differences. CONCLUSIONS: The epidemiology is similar to those reported from other parts of the world, but the ocular presentation seems to be milder than in Caucasians.
format Online
Article
Text
id pubmed-5793449
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-57934492018-02-08 Epidemiology and Clinical Features of Thyroid-associated Orbitopathy in Accra Ackuaku-Dogbe, Edith Mawunyo Akpalu, Josephine Abaidoo, Benjamin Middle East Afr J Ophthalmol Original Article PURPOSE: Thyroid-associated orbitopathy (TAO), a clinical manifestation of Graves' disease, is an autoimmune disorder of the orbital and periorbital tissue. Data on the epidemiology and clinical presentation of TAO in Africa are generally scarce and unavailable in Ghana. We investigated the epidemiology and clinical features of TAO among patients with thyroid disorders attending the Korle Bu Teaching Hospital, Accra. SUBJECTS AND METHODS: This was a descriptive cross-sectional study of patients diagnosed with thyroid disorders which was conducted at the endocrine and orbital clinics of the Korle Bu Teaching Hospital. Diagnosis was based on clinical features and confirmed by a thyroid function test. Data collected and analyzed included demography, systemic and ocular features of thyroid disorder, and thyroid function tests. RESULTS: Of the 194 patients with thyroid disorders recruited, 117 (60.30%) had TAO. The mean age was 45.22 years (standard deviation: 13.90). The male:female ratio was 1:4.45. The most common ocular symptoms were “bulging eyes” (76/65.00%) and “puffy eyelid” (62/53.00%), and the common signs were eyelid retraction (97/82.91%) and proptosis (80/68.38%). Mild TAO was diagnosed in 64.96% of patients with only 6.84% having the severe form. The outcomes of the thyroid function test, thyroid disorder, and severity of TAO did not record any statistically significant differences. CONCLUSIONS: The epidemiology is similar to those reported from other parts of the world, but the ocular presentation seems to be milder than in Caucasians. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5793449/ /pubmed/29422752 http://dx.doi.org/10.4103/meajo.MEAJO_91_17 Text en Copyright: © 2018 Middle East African Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Ackuaku-Dogbe, Edith Mawunyo
Akpalu, Josephine
Abaidoo, Benjamin
Epidemiology and Clinical Features of Thyroid-associated Orbitopathy in Accra
title Epidemiology and Clinical Features of Thyroid-associated Orbitopathy in Accra
title_full Epidemiology and Clinical Features of Thyroid-associated Orbitopathy in Accra
title_fullStr Epidemiology and Clinical Features of Thyroid-associated Orbitopathy in Accra
title_full_unstemmed Epidemiology and Clinical Features of Thyroid-associated Orbitopathy in Accra
title_short Epidemiology and Clinical Features of Thyroid-associated Orbitopathy in Accra
title_sort epidemiology and clinical features of thyroid-associated orbitopathy in accra
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793449/
https://www.ncbi.nlm.nih.gov/pubmed/29422752
http://dx.doi.org/10.4103/meajo.MEAJO_91_17
work_keys_str_mv AT ackuakudogbeedithmawunyo epidemiologyandclinicalfeaturesofthyroidassociatedorbitopathyinaccra
AT akpalujosephine epidemiologyandclinicalfeaturesofthyroidassociatedorbitopathyinaccra
AT abaidoobenjamin epidemiologyandclinicalfeaturesofthyroidassociatedorbitopathyinaccra